Rare diseases
Investigational molecules
Locations
Carrer De Baldiri Reixac 4, Poligono Industrial Parc Cientific De Barcelona, 08028 Barcelona, Spain
Idp Discovery Pharma S.L. is active in clinical research for relapsed and refractory blood cancers, with studies involving multiple myeloma, B-cell lymphomas, and chronic lymphocytic leukemia. Its trial portfolio reflects a focus on malignancies of the lymphoid and plasma cell lineages.
The sponsor’s hematology research includes both standalone and combination treatment settings across relapsed/refractory disease.
Idp Discovery Pharma S.L. runs clinical trials in conditions such as Small cell lung cancer metastatic, Chronic lymphocytic leukaemia, B-cell lymphoma, Plasma cell myeloma, among others.
Clinical trials run by this sponsor – those enrolling participants first.
SpainSpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
